Krystal Biotech (KRYS) PT Raised to $403 at TD Cowen

June 18, 2026 7:48 AM

TD Cowen analyst Ritu Baral raised the price target on Krystal Biotech (NASDAQ: KRYS) to $403.00 (from $306.00) while maintaining a Buy rating.

No results found